QDx Pathology Services Revenue and Competitors

Cranford Township, NJ USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • QDx Pathology Services's estimated annual revenue is currently $47.5M per year.(i)
  • QDx Pathology Services's estimated revenue per employee is $297,000

Employee Data

  • QDx Pathology Services has 160 Employees.(i)
  • QDx Pathology Services grew their employee count by 3% last year.

QDx Pathology Services's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
VP Sales and MarketingReveal Email/Phone
4
VP TechnologyReveal Email/Phone
5
SVP OperationsReveal Email/Phone
6
VP, Laboratory ServicesReveal Email/Phone
7
Chief Financial Officer (LabGenomics)Reveal Email/Phone
8
DirectorReveal Email/Phone
9
Human Resources ManagerReveal Email/Phone
10
Revenue Cycle ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M52-4%N/AN/A
#2
$275.2M72828%N/AN/A
#3
$35.9M13310%N/AN/A
#4
$11050M288364%$48.1MN/A
#5
$18.2M7521%N/AN/A
#6
$17M703%N/AN/A
#7
$25.1M93-10%N/AN/A
#8
$24M8910%N/AN/A
#9
$17M7015%N/AN/A
#10
$9.7M45-6%N/AN/A
Add Company

What Is QDx Pathology Services?

QDx Pathology is a national, independent, and full-service anatomical and molecular pathology laboratory dedicated to providing diagnostic excellence. Our CAP-certified facility utilizes the latest state-of-the-art instrumentation and medical technology. Our staff of experienced, board-certified pathologists and cytotechnologists strive to meet the high standards of care that our clinical practices to their patients. Official Lab Partner for EUA FDA Approved COVID-19 Patient Take Home Tests You can lean on QDx for your COVID-19 testing needs. QDx has multiplied their testing capacity in order to help Americans stay healthy. Getting people safely back into work and the community is a top priority. #CovidTesting #Pathology #Gastroenterology #Urology

keywords:N/A

N/A

Total Funding

160

Number of Employees

$47.5M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator